Investigating Denosumab discontinuation in the TgRANKL osteoporotic mouse model
Vagelis Rinotas,
Eleftheria-Dimitra Ntouskou,
Melina Dragolia,
Vasileios Ntafis,
Maria Yavropoulou,
Athanasios Anastasilakis,
Polyzois Makras,
Eleni Douni
Affiliations
Vagelis Rinotas
Biomedical Sciences Research Center ''Alexander Fleming'', Institute for Bioinnovation, Athens, Greece; Agricultural University of Athens, Department of Biotechnology, Athens, Greece
Eleftheria-Dimitra Ntouskou
Biomedical Sciences Research Center ''Alexander Fleming'', Institute for Bioinnovation, Athens, Greece
Melina Dragolia
Biomedical Sciences Research Center ''Alexander Fleming'', Institute for Bioinnovation, Athens, Greece
Vasileios Ntafis
Biomedical Sciences Research Center ''Alexander Fleming'', Institute for Bioinnovation, Athens, Greece
Maria Yavropoulou
Medical School- National and Kapodistrian University of Athens, Endocrinology Unit- 1st Department of Propaedeutic and Internal Medicine, Athens, Greece
Athanasios Anastasilakis
424 General Military Hospital, Department of Endocrinology, Thessaloniki, Greece
Polyzois Makras
251 Hellenic Air Force & VA General Hospital, Department of Endocrinology and Diabetes and Department of Medical Research, Athens, Greece
Eleni Douni
Biomedical Sciences Research Center ''Alexander Fleming'', Institute for Bioinnovation, Athens, Greece; Agricultural University of Athens, Department of Biotechnology, Athens, Greece; Corresponding author.
